Marc Banjak
Conseiller Juridique Général chez DOVA PHARMACEUTICALS, INC.
Postes actifs de Marc Banjak
Sociétés | Poste | Début | Fin |
---|---|---|---|
DOVA PHARMACEUTICALS, INC. | Conseiller Juridique Général | - | - |
IBIO, INC. | Conseiller Juridique Général | - | - |
Secrétaire Général | - | - |
Historique de carrière de Marc Banjak
Anciens postes connus de Marc Banjak
Sociétés | Poste | Début | Fin |
---|---|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Comptroller/Controller/Auditor | - | - |
Formation de Marc Banjak
Sturm College of Law | Doctorate Degree |
Franklin & Marshall College | Undergraduate Degree |
University of Denver | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
General Counsel | 2 |
Corporate Secretary | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
IBIO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Bourse
- Insiders
- Marc Banjak
- Expérience